Lung Cancers Terminated Phase 4 Trials for Ibandronate (DB00710)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00492843Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal MetastasisTreatment